Topic
Generic Entry
ANDA approvals, authorized generics, generic launch sequencing, patent expiry, and formulary shifts after generic entry.
Pricing & Access· May 17, 2026 · 10 min read
Farxiga coverage guide: formulary, prior authorization, and what access teams should know
Farxiga (dapagliflozin) is an SGLT2 inhibitor approved for type 2 diabetes, heart failure, and chronic kidney disease. This guide maps FDA indications, dosing, formulary...